# Tenecteplase in Wake-up Ischaemic Stroke Trial

> **NCT03181360** · PHASE3 · UNKNOWN · sponsor: **University Hospital of North Norway** · enrollment: 600 (estimated)

## Conditions studied

- Ischemic Stroke
- Stroke, Acute

## Interventions

- **DRUG:** Tenecteplase
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT03181360
- **Lead sponsor:** University Hospital of North Norway
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03181360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03181360, "Tenecteplase in Wake-up Ischaemic Stroke Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03181360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*